KR20210010682A - Cleansing composition for women's vagina comprising natural - Google Patents

Cleansing composition for women's vagina comprising natural Download PDF

Info

Publication number
KR20210010682A
KR20210010682A KR1020190086098A KR20190086098A KR20210010682A KR 20210010682 A KR20210010682 A KR 20210010682A KR 1020190086098 A KR1020190086098 A KR 1020190086098A KR 20190086098 A KR20190086098 A KR 20190086098A KR 20210010682 A KR20210010682 A KR 20210010682A
Authority
KR
South Korea
Prior art keywords
composition
extract
vagina
feminine
vitamin
Prior art date
Application number
KR1020190086098A
Other languages
Korean (ko)
Other versions
KR102224920B1 (en
Inventor
김주희
류충호
Original Assignee
(주)인벤티지랩
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)인벤티지랩 filed Critical (주)인벤티지랩
Priority to KR1020190086098A priority Critical patent/KR102224920B1/en
Priority to CN202010206229.6A priority patent/CN112237625A/en
Publication of KR20210010682A publication Critical patent/KR20210010682A/en
Application granted granted Critical
Publication of KR102224920B1 publication Critical patent/KR102224920B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A61K8/988Honey; Royal jelly, Propolis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41881,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415Pyridoxine, i.e. Vitamin B6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51Thiamines, e.g. vitamin B1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525Isoalloxazines, e.g. riboflavins, vitamin B2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • A61K31/714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/722Chitin, chitosan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/064Saccharomycetales, e.g. baker's yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/736Chitin; Chitosan; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Zoology (AREA)
  • Insects & Arthropods (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)

Abstract

The present invention relates to a composition for feminine washes comprising a natural extract. The present invention relates to a composition for feminine washes having excellent preventive and therapeutic effects of vaginal diseases, and at the same time, including natural extracts, thereby causing little irritation when used, providing a healthier environment, and having excellent antibacterial activity.

Description

천연 추출물을 포함하는 여성 청결제용 조성물{CLEANSING COMPOSITION FOR WOMEN'S VAGINA COMPRISING NATURAL}Composition for feminine cleansing agent containing natural extract {CLEANSING COMPOSITION FOR WOMEN'S VAGINA COMPRISING NATURAL}

본 발명은 천연 추출물을 포함하는 여성 청결제용 조성물에 관한 것이다. 보다 구체적으로, 천연 추출물을 주성분으로 포함하여, 여성의 질과 관련된 질환의 예방 및 치료를 위한 여성 청결제용 조성물에 관한 것이다.The present invention relates to a composition for a feminine cleanser comprising a natural extract. More specifically, it relates to a composition for a female cleanser for the prevention and treatment of diseases related to the vagina of women, including a natural extract as a main component.

여성의 질은 외음부와 자궁의 연결 통로로 여성의 몸에서 가장 습기가 많고 따뜻한 곳이다. 따라서 질염의 주원인인 세균이나 곰팡이가 서식하기 적합한 환경이므로 그로 인한 질환이 발생할 가능성이 크다. 정상적인 조건에서는 질 내부에 많은 유산균이 서식하면서 질 내부를 약산성으로 만들어 병원균이나 곰팡이가 증식하는 것을 억제하지만, 항생제 장기복용이나 피임약 장기복용, 탐폰이나 루프사용 또는 임신이나 출산, 수유, 폐경 등으로 여성 호르몬의 균형 변화 등의 이유로 질 내부의 균형이 깨어질 때 질 내에서 정상적인 조건에서는 성장이 통상적으로 억제되는 기회감염성 병원체의 증식이 일어나 질염이 발병할 수 있다. 질염은 세균성 질염(bacterial vaginosis), 칸디다성 질염(Candida vaginitis), 트리코모나스 질염(Trichomonas vaginitis), 위축성 질염 (Atrophic vaginitis)등이 보고되어 있다.A woman's vagina is the passageway between the vulva and the uterus, and is the most humid and warm place in a woman's body. Therefore, since it is an environment suitable for bacteria or fungi, which are the main causes of vaginitis, there is a high possibility of disease. Under normal conditions, many lactobacilli inhabit the vagina and make the vagina weakly acidic to suppress the growth of pathogens or fungi, but women who take antibiotics for a long time, take contraceptives for a long time, use tampons or loops, or are pregnant, childbirth, lactation, menopause, etc. When the balance of the vagina is broken due to changes in the balance of hormones, vaginitis may occur due to the proliferation of opportunistic pathogens that normally inhibit growth under normal conditions in the vagina. As vaginitis, bacterial vaginosis, Candida vaginitis, Trichomonas vaginitis, and atrophic vaginitis have been reported.

가장 흔한 질환은 세균성 질염(Bacterial vaginosis)으로, 가드네렐라 바지날리스 (Gardnerella vaginalis)에 의해 발병한다. 이 질염은 질 내 산도의 불균형으로 질 내에 서식하는 유산균이 줄어드는 반면 1%미만으로 존재하던 혐기성 세균이 과증식 하여 발생한다. 정상 질 세균총의 변화를 일으키는 유발인자에 관해서는 알려져 있지 않으나, 잦은 성교나 질 세척으로 질의 반복되는 알칼리성화가 그 역할을 하는 것으로 추정되고 있다. 정상적으로 있어야 할 과산화수소를 생성하는 유산균이 소실되면 정상 질 세균총의 재생은 어려워지기 때문에 세균성 질염의 재발이 자주 일어난다. The most common disease is bacterial vaginosis, which is caused by Gardnerella vaginalis. This vaginitis is caused by overgrowth of anaerobic bacteria that existed in less than 1% while the number of lactic acid bacteria in the vagina decreases due to an imbalance in vaginal acidity. Although the causative factor that causes changes in the normal vaginal flora is not known, it is estimated that repeated alkalizing of the vagina with frequent intercourse or vaginal washing plays a role. When the lactic acid bacteria that produce hydrogen peroxide, which should normally be present, are lost, the regeneration of the normal vaginal flora becomes difficult, so recurrence of bacterial vaginosis often occurs.

또한 세균성 질염을 가진 여성은 골반내 감염 (Pelvic inflammatory disease, PID), 유산 후 PID, 자궁 절제술 후 질정염(postoperative cuff cellulitis), 비정상 자궁경부 세포진 등 심각한 후유증의 빈도가 높아지며 임산부는 조기 양막파수, 조기진통, 조산, 융모양막염(chorioamnionitis), 제왕절개술 후 자궁내막염 등의 위험이 있다.In addition, women with bacterial vaginosis have a higher frequency of serious sequelae, such as pelvic inflammatory disease (PID), post-abortion PID, postoperative cuff cellulitis, and abnormal cervical papillae. There is a risk of premature labor, preterm labor, chorioamnionitis, and endometritis after cesarean section.

세균성 질염과 함께 흔한 질환인 칸디다성 질염 (Candida vaginitis)은 진균인 칸디다 알비칸스 (Candida albicans)균이 습한 음부에 서식하면서 염증을 일으키는 질환으로서, 약 75%의 여성이 살아가는 동안 한 번 이상 질과 외음부의 칸디다성 질염을 겪으며 45%의 여성이 1년에 2회 이상의 재발을 겪는 흔한 질환이다. 건강한 사람의 구강, 장, 질 등에 정상적으로 보유하고 있는 칸디다(주로 Candida albicans)가 임신이나 경구용 피임약 장기 복용 등으로 여성 호르몬의 상태가 비정상적일 때, 감기나 당뇨병, 에이즈의 이유로 면역성이 극도로 쇠약할 때 감염을 유발하게 된다. 비만, 항생제의 알레르기나 관절염 등의 치료제로 쓰이는 부신 피질 호르몬의 복용 등에 의해서도 발병할 수 있다. 항생제의 투여로 인한 발병의 경우 항생제가 질 내의 유익한 유산균을 죽임으로써 발생하는데 이런 경우 재발의 가능성도 크다. 너무 꼭 끼는 거들이나 바지 등을 입어 통풍이 안 되거나 목욕 후 외음부의 물기를 잘 닦지 않아 젖은 팬티를 입은 경우, 생리 중 패드를 자주 갈지 않는 경우에도 잘 발생한다. 질에 칸디다 알비칸스가 서식하고 있는 여성의 50%만이 증상이 있는데 주증상은 냉이 많아지고 피부에 염증 반응이 생겨서 가려운 것이며, 병의 종류와 정도 또는 2차 세균 감염 등에 따라서 피부가 벗겨지거나 고름이 나오는 등 차이가 있다. 특징적 증상으로는 짙고 하얀 분비물이 나오며, 외음부는 매우 신경이 예민하여 아프거나 때로 부종과 염증이 생기기도 한다. 작열감, 성교통, 부종, 외음부 통증 등이 있고 임상 소견으로는 외음부 및 질의 홍반, 울혈, 표피박리, 소포, 농포, 등을 볼 수 있다.Candida vaginitis, a common disease along with bacterial vaginitis, is a disease in which the fungus Candida albicans lives in the moist vagina and causes inflammation.About 75% of women live with the vagina more than once during their lives. It is a common disease in which 45% of women suffer from candidal vaginitis of the vulva and have more than two recurrences per year. Candida (mainly Candida albicans), which is normally held in the oral, intestine, and vagina of a healthy person, is extremely weak due to a cold, diabetes, or AIDS when the female hormone status is abnormal due to pregnancy or long-term use of oral contraceptives. When it does, it causes an infection. Obesity, antibiotic allergy, and taking corticosteroids used to treat arthritis can also cause the disease. In the case of outbreaks caused by the administration of antibiotics, antibiotics are caused by killing beneficial lactic acid bacteria in the vagina, and in this case, the possibility of recurrence is high. It can also occur if you wear tight girdles or pants that prevent ventilation, or if you wear wet panties because you do not dry the vulva after bathing, or if you do not change pads frequently during menstruation. Only 50% of women living with Candida albicans in the vagina have symptoms. The main symptoms are itching due to increased coldness and inflammatory reactions in the skin, and skin peeling or pus occurs depending on the type and severity of the disease or secondary bacterial infection. There are differences, such as coming out. Characteristic symptoms include dark and white secretions, and the vulva is very sensitive to nerves, causing pain or sometimes swelling and inflammation. There are burning sensation, dyspareunia, swelling, and vulvar pain, and clinical findings include erythema, congestion, epidermal detachment, vesicles, pustules, and the like.

이와 같은 여성 질환을 예방하기 위하여 청결제(질세정제), 외음부 세정제를 사용하는 경우가 많다. 질염을 예방하기 위해 일반적으로 사용되고 있는 국부용 세정제로는 지방산류 또는 증류된 라우릴알코올 (lauryl alcohol) 등을 설폰화 하고 완화제, 점증제, 영양제, 기포제, 유기 살균제 등을 합성한 투명 또는 로션(lotion) 타입의 것이 출하된 바 있다. 또한 세정력을 지닌 계면 활성제 및 의약품으로서의 포비돈-요오드를 주성분으로 하는 것도 있다. 상기한 화학적 합성에 의한 소독제인 포비돈-요오드는 칸디다성 질염, 트리코모나스 질염 및 기타 질 감염증의 예방 및 치료에 효능이 있는 것으로 알려져 있으나, 요오드 등의 과민 증상이나 점막 손상에 의한 소양감, 작열감, 피부 궤양, 접촉성 피부염 등을 일으킬 우려가 있으며 질내 무기 요오드 또는 혈중 총 요오드수치가 상승하여 갑상선 기능 저하증을 유발할 수 있는 것으로 알려져 있다.To prevent such female diseases, cleaners (vaginal cleaners) and vulvar cleaners are often used. As a topical cleaning agent generally used to prevent vaginitis, a transparent or lotion that is synthesized by sulfonating fatty acids or distilled lauryl alcohol and synthesizing emollients, thickeners, nutrients, foaming agents, organic disinfectants, etc. lotion) type has been shipped. There are also surfactants with detergency and povidone-iodine as pharmaceuticals as main components. Povidone-iodine, a disinfectant by the above chemical synthesis, is known to be effective in the prevention and treatment of Candida vaginitis, Trichomonas vaginitis and other vaginal infections, but itching sensation, burning sensation due to hypersensitivity symptoms such as iodine or damage to the mucous membrane, skin ulcers It is known that it may cause contact dermatitis, and may cause hypothyroidism by increasing the level of inorganic iodine in the vagina or total iodine in the blood.

상기한 바와 같은 의약품으로서의 소독제의 사용에 의한 부작용을 해소하기 위한 종래의 기술로서는, 건강한 여성의 경우 질내 유익 미생물에 의한 젖산 분비에 의해 질 내 산도가 pH3.2로 유지되며 이러한 낮은 산도에서는 대부분의 유해균이 증식 억제 내지 사멸한다는 점에 기초하여, 젖산을 주성분으로 하며 우유에서 추출한 락토세럼 (lactoserum)을 첨가한 pH3.5의 완충 용액 제제가 제안되어 있으나, 이것은 여성용 청결제라고 하기 보다는 질내 pH를 정상 상태로 유지시키는 질내 적정 산도 유지제이며, 근본적인 치료와 예방을 기대하기 힘들다.As a conventional technique for solving the side effects caused by the use of disinfectants as pharmaceuticals as described above, in the case of healthy women, the vaginal acidity is maintained at pH 3.2 by secretion of lactic acid by beneficial microorganisms in the vagina. Based on the fact that harmful bacteria are inhibited from proliferation or killed, a buffered solution formulation of pH 3.5 with lactose as a main component and lactoserum extracted from milk has been proposed, but this is not a feminine cleanser, but rather a normal vaginal pH. It is a vaginal acidity maintenance agent that keeps it in a state, and it is difficult to expect fundamental treatment and prevention.

그러므로, 이와 같은 여성의 질과 관련된 질환 예방에 효과적일 수 있는 질내 pH를 정상 상태로 유지시켜줄 수 있으며, 저자극성으로 사용이 용이한 여성청결제 혹은 외음부 세정제로, 천연 성분이 기능성으로 포함되어 사용 시 보다 건강한 환경을 제공할 수 있는 여성 청결제에 대한 개발이 필요로 되고 있다.Therefore, it can keep the vaginal pH in a normal state, which can be effective in preventing such diseases related to the vagina of women, and it is a hypoallergenic and easy-to-use feminine cleaner or vulvar cleaner. There is a need to develop feminine cleansers that can provide a healthier environment.

KR 10-2015-0148530 B1KR 10-2015-0148530 B1

본 발명의 목적은 여성의 관련된 질환의 예방 또는 치료에 효과적인 천연 추출물을 포함하는 여성 청결제용 조성물을 제공하는 것이다.It is an object of the present invention to provide a composition for a feminine cleansing agent comprising a natural extract effective in preventing or treating women's related diseases.

본 발명의 다른 목적은 질과 관련된 질환의 예방 및 치료 효과가 우수함과 동시에 천연 추출물을 포함하여 사용 시 자극이 거의 없고, 보다 건강한 환경을 제공할 수 있으며, 항균 활성이 우수한 여성 청결제용 조성물을 제공하는 것이다.Another object of the present invention is to provide a composition for a feminine cleaner having excellent antimicrobial activity, which is excellent in preventing and treating diseases related to the vagina, and at the same time, there is little irritation when used, including a natural extract, and can provide a healthier environment. Is to do.

상기 목적을 달성하기 위하여, 본 발명의 일 실시예에 따른 천연 추출물을 포함하는 여성 청결제용 조성물은 프로폴리스; 콜라겐 펩타이드; 흑효모; 키토산; 당귀 추출물, 병풀 추출물, 자몽씨 추출물 및 이들의 혼합물로 이루어진 군으로부터 선택되는 천연 추출물; 및 수용성 비타민; 을 포함한다.In order to achieve the above object, a composition for a feminine cleanser comprising a natural extract according to an embodiment of the present invention is propolis; Collagen peptide; Black yeast; Chitosan; Angelicae extract, centella extract, grapefruit seed extract, and a natural extract selected from the group consisting of a mixture thereof; And water-soluble vitamins; Includes.

상기 조성물은 질과 관련된 질환의 예방 또는 치료를 위한 것으로, 상기 질과 관련된 질환은 질이완증, 질 건조증, 질 진균증 및 냉대하증인 것을 포함한다.The composition is for the prevention or treatment of diseases related to the vagina, and the diseases related to the vagina include vaginosis, vaginal dryness, vaginal mycosis and hypochondriasis.

상기 조성물은 진균류인 칸디다알비칸스(Candida albicans)에 항균 활성 효과가 있는 것을 포함한다.The composition includes those having an antimicrobial effect on the fungus Candida albicans.

상기 수용성 비타민은 비타민 C, 비타민 B1, 비타민 B2, 니아신, 비타민 B6, 비타민 B12, 엽산 및 비오틴으로 이루어진 군으로부터 선택되는 것을 포함한다.The water-soluble vitamins include those selected from the group consisting of vitamin C, vitamin B1, vitamin B2, niacin, vitamin B6, vitamin B12, folic acid, and biotin.

상기 조성물은 기타 첨가제를 추가로 포함하며, 상기 기타 첨가제는 부형제, 붕해제 및 활택제인 것을 포함한다.The composition further includes other additives, and the other additives include excipients, disintegrants and lubricants.

상기 조성물은 세정 조성물 또는 질내 삽입용 정제인 조성물인 것을 포함한다.The composition includes a composition that is a cleaning composition or a tablet for vaginal insertion.

상기 조성물은 제2 천연 추출물을 추가로 포함하며, 상기 제2 천연 추출물은 구릿대 추출물, 섬바디 추출물 및 이들의 혼합물로 이루어진 군에서 선택되는 것을 포함한다,The composition further comprises a second natural extract, and the second natural extract includes one selected from the group consisting of beetroot extract, island body extract, and mixtures thereof.

이하, 본 발명을 더욱 상세하게 설명한다.Hereinafter, the present invention will be described in more detail.

본 명세서에서 사용되는 용어 '추출물'은 상술한 바와 같이 당업계에서 조추출물(crude extract)로 통용되는 의미를 갖지만, 광의적으로는 추출물을 추가적으로 분획(fractionation)한 분획물도 포함한다. 즉, 추출물은 상술한 추출용매를 이용하여 얻은 것뿐만 아니라, 여기에 정제과정을 추가적으로 적용하여 얻은 것도 포함한다. 예컨대, 상기 추출물을 일정한 분자량 컷-오프 값을 갖는 한외 여과막을 통과시켜 얻은 분획, 다양한 크로마토그래피(크기, 전하, 소수성 또는 친화성에 따른 분리를 위해 제작된 것)에 의한 분리 등, 추가적으로 실시된 다양한 정제 방법을 통해 얻어진 분획도 본 발명의 추출물에 포함되는 것이다.As used herein, the term'extract' has the meaning commonly used as a crude extract in the art as described above, but broadly includes a fraction obtained by further fractionating the extract. That is, the extract includes not only those obtained using the above-described extraction solvent, but also those obtained by additionally applying a purification process thereto. For example, fractions obtained by passing the extract through an ultrafiltration membrane having a certain molecular weight cut-off value, separation by various chromatography (made for separation according to size, charge, hydrophobicity or affinity), etc. Fractions obtained through the purification method are also included in the extract of the present invention.

본 발명의 일 실시예에 따른 천연 추출물을 포함하는 여성 청결제용 조성물은 프로폴리스; 콜라겐 펩타이드; 흑효모; 키토산; 당귀 추출물, 병풀 추출물, 자몽씨 추출물 및 이들의 혼합물로 이루어진 군으로부터 선택되는 천연 추출물; 및 수용성 비타민; 을 포함한다.The composition for a feminine cleanser comprising a natural extract according to an embodiment of the present invention is propolis; Collagen peptide; Black yeast; Chitosan; Angelicae extract, centella extract, grapefruit seed extract, and a natural extract selected from the group consisting of a mixture thereof; And water-soluble vitamins; Includes.

상기 프로폴리스(Propolis)는 꿀벌이 나무의 싹이나 수액과 같은 식물로부터 수집하는 수지질(樹脂質)의 혼합물로서 천연항균물질이다. 항균, 살균 작용과 면역력 활성화, 면역기능 강화작용, 세포활성화 및 세포재생 작용, 항 알레르기작용, 유전자 손상 방어작용, 혈관 강화작용, 항산화작용, 항암제 부작용의 경감작용 등이 있다. 또한, 프로폴리스는 증상을 조절하는 작용을 하기도 한다.The propolis is a natural antibacterial substance as a mixture of resinous substances collected from plants such as tree shoots and sap by bees. It has antibacterial, bactericidal and immune activation, immune function strengthening, cell activation and cell regeneration, anti-allergic, gene damage defense, blood vessel strengthening, antioxidant, and anticancer drug side effects. Also, propolis works to control symptoms.

상기 프로폴리스는 항균, 항염 및 항산화 효과를 위해 포함되는 것이며, 천연 추출물은 피부 트러블 완화, 보습, 피부 유연, 피부 탄력, 피부 재생, 혈액 순환 개선 및 민감성 피부 진정 등을 위해 포함되는 것이다. The propolis is included for antibacterial, anti-inflammatory and antioxidant effects, and natural extracts are included for skin trouble relief, moisturizing, skin softening, skin elasticity, skin regeneration, improved blood circulation, and soothing sensitive skin.

즉, 프로폴리스를 여성 청결제용 조성물에 포함시킴에 따라, 질과 관련된 질환의 예방 또는 치료를 위한, 항균, 항염 및 항산화 효과를 나타낼 수 있으나, 이로 인해, 피부에 자극이 발생하는 문제가 발생할 수 있고, 이러한 문제를 본 발명에서는 천연 추출물을 추가로 포함함에 따라 해결하고자 한다.That is, as propolis is included in the composition for feminine cleansing, it may exhibit antibacterial, anti-inflammatory and antioxidant effects for the prevention or treatment of vaginal-related diseases, but this may cause skin irritation. And, in the present invention, this problem is to be solved by additionally including a natural extract.

흑효모(Aureobasidium pullulans)는 베타글루칸을 다량 함유하고 있는 것으로 보습, 탄력, 아토피 소양 중에 효과가 우수한 것으로 알려져 있다. 상기 베타글로칸은 효모의 세포벽을 구성하고 있어 천연 보습인자 역할을 하는 아미노산은 보습과 함께 탄력을 더해주며, 피부 친화력이 우수하여 면연력을 증가시킬 수 있다.Black yeast (Aureobasidium pullulans) contains a large amount of beta-glucan and is known to be excellent in moisturizing, elasticity, and atopic pruritus. Since beta-glocans constitute the cell wall of yeast, amino acids that act as natural moisturizing factors add elasticity as well as moisturization, and excellent skin affinity can increase immunity.

키토산(Chitosan)은 갑각류에 함유되어 있는 키틴을 인체에 흡수되도록 가공한 물질로 체내 중금속 및 오염 물질 배출 등의 효과가 있으며, 우수한 항균 효과 및 보습 효과를 증가시킬 수 있다.Chitosan is a material processed so that chitin contained in crustaceans is absorbed by the human body. It has the effect of discharging heavy metals and pollutants in the body, and can increase excellent antibacterial and moisturizing effects.

상기 당귀는 다양한 약리학적 효과가 알려져 있는데 대표적으로는 빈혈치료, 진정작용, 진통효과, 강장제, 월경통치료, 폐경기증후치료, 복통치료, 상처치료, 관절염치료, 당뇨성 고혈압치료의 작용이 있다는 것이 밝혀졌다. 당귀에는 쿠마린 계통의 다양한 물질이 존재한다는 것이 알려져 있고 대표적으로는 decursin과 decursinol angelate가 다량 함유되어 있다는 것이 오래전(1967년)에 보고되기도 했으며, 최근에는 dihydropyrano coumarin 계열이 물질이 항암효과가 있다고 보고되기도 했다. Angelica has known various pharmacological effects. Representatively, it has been found that anemia treatment, sedation, analgesic effect, tonic, menstrual pain treatment, menopausal symptom treatment, abdominal pain treatment, wound treatment, arthritis treatment, diabetic hypertension treatment. lost. It is known that there are various substances of the coumarin family in Angelica, and it was reported long ago (1967) that a large amount of decursin and decursinol angelate is contained, and recently, dihydropyrano coumarin-based substances have been reported to have anticancer effects. did.

상기 병풀(centella asiatica extract)은 인도양의 열대지방에서 기원한 것으로 습하고 그늘진 해발 600미터에서 이상적으로 자생하는 식물로서 gotu kola, indian pennywork 또는 tiger grass라고도 불리운다. 이러한 병풀에는 Triterpenoids(사포닌)라 불리는 아시아티코사이드(asiaticoside), 마데코글리코사이드(madecasosside), 아시아틱산(asiatic acid) 및 마데카식산(madecassic acid) 성분이 존재하며 이들은 인체의 콜라겐 합성을 조절 및 촉진하는 작용을 하고, 현관을 강화하여 혈행을 촉진하며, 기억력 향상에 도움이 되는 것으로 알려져 있다.Centella asiatica extract is a plant that originates in the tropical regions of the Indian Ocean and grows ideally at an altitude of 600 meters above sea level in humid and shady areas, and is also called gotu kola, indian pennywork or tiger grass. These centella asiaticoside, madecasosside, asiatic acid and madecassic acid, called triterpenoids (saponins), are present in the body, and they regulate collagen synthesis in the human body. It is known to promote blood circulation by strengthening the vestibule, and to help improve memory.

자몽씨(Grapefruits Seed)는 자몽씨에서 추출한 천연 산화방지제로 천연의 살균, 소독, 방부제로서 의학적으로는 박테리아나 세균 감염에 내복 약으로 상처나 중이염, 인후염 등에 외용약으로도 쓰인다. 또한, 세균과 곰팡이 등의 부패성 및 병원성 미생물에 대해 강력한 살균 효과가 있다.Grapefruits Seed is a natural antioxidant extracted from grapefruit seeds. It is a natural sterilization, disinfection, and preservative. Medically, it is used as an internal medicine for bacterial or bacterial infections, as well as external medicine for wounds, otitis media, and sore throat. In addition, it has a strong sterilizing effect against decaying and pathogenic microorganisms such as bacteria and fungi.

상기 흑효모, 키토산, 당귀 추출물, 병풀 추출물 및 자몽씨 추출물은 전체 중량에 대하여, 각각 0.1 내지 1.5 중량%로 포함될 수 있으며, 상기 예시에 국한되지 않는다.The black yeast, chitosan, angelica extract, centella extract and grapefruit seed extract may be included in an amount of 0.1 to 1.5% by weight, respectively, based on the total weight, and are not limited to the above examples.

상기 천연 추출물은 당해 기술 분야의 전문가에 의해 추출할 수 있는 일반적인 추출방법으로 추출된 추출물을 의미하며, 추출물은 분말 형태로 이용될 수 있으며, 상기 예시에 국한되지 않는다.The natural extract refers to an extract extracted by a general extraction method that can be extracted by an expert in the art, and the extract may be used in a powder form, but is not limited to the above example.

상기 조성물은 질과 관련된 질환의 예방 또는 치료를 위한 것으로, 상기 질과 관련된 질환은 질이완증, 질 건조증, 질 진균증 및 냉대하증인 것을 포함한다.The composition is for the prevention or treatment of diseases related to the vagina, and the diseases related to the vagina include vaginosis, vaginal dryness, vaginal mycosis and hypochondriasis.

상기 질과 관련된 질환은 질 분비물, 냄새, 작열감, 소양감, 성교통, 배뇨통 등의 증상을 특징으로 하는 질의 감염 또는 염증 상태를 말하는 것이다.The vaginal-related disease refers to an infection or inflammatory condition of the vagina characterized by symptoms such as vaginal discharge, smell, burning, itching, dyspareunia, and urinary pain.

질이완증은 질 주위의 근육과 질 입구 근육이 처지고 질 점막이 감속하여 근막이 이완되는 증상으로 질의 탄력이 저하되기 때문에 성감이 약해져 성관계 시 불감증이 있을 수가 있으며, 심할 경우 여성으로서의 자신감의 결여되는 상황에 이른다.Vaginal dyslexia is a symptom of sagging the muscles around the vagina and the muscles at the entrance to the vagina, and the fascia relaxes due to the slowing of the vaginal mucosa.Because the elasticity of the vagina decreases, the sexual sensation may be weakened, leading to insensitivity during sexual intercourse. Comes to the situation.

질건조증은 애액이 부족한 체질이거나 자궁과 질 주변의 혈류량과 혈액순환감소로 정상적으로 나와야 할 질 분비액이 줄어드는 현상으로 여성호르몬이 감소하면 탄력성과 유연성을 잃은 질과 요도계의 상피세포가 얇아지면서 주로 발생한다. 질 건조가 오래 지속되면 면역력이 떨어져 여러 가지 질환에 노출될 수 있으며, 수축력 감퇴로 인한 요실금, 자궁이탈 등의 위험이 뒤따른다.Vaginal dryness is a phenomenon in which vaginal secretions that should normally come out due to a decrease in blood flow and blood circulation around the uterus and vagina are reduced or the epithelial cells of the vagina and urethra that lose elasticity and flexibility become thinner when female hormones decrease. do. If the vaginal dryness lasts for a long time, the immunity decreases, and you may be exposed to various diseases, and there is a risk of urinary incontinence and uterine dislocation due to decreased contractility.

질 진균증은 칸디다균에 의해 유발된 질염으로 칸디다균이 습한 음부에 서식하면서 염증을 일으키는 가장 흔한 질염 중 하나이다. 주증상은 냉이 많아지고 피부에 염증 반응이 생겨 가려움을 느낀다. 또한 병의 종류와 정도, 2차 세균 감염 등에 따라 피부가 벗겨지거나 고름이 나오는 등 차이가 있다.Vaginal mycosis is a vaginitis caused by Candida and is one of the most common vaginitis that causes inflammation when Candida lives in the moist vagina. The main symptom is coldness and an inflammatory reaction to the skin, which makes you feel itchy. In addition, there are differences, such as peeling of the skin or pus, depending on the type and severity of the disease and secondary bacterial infection.

냉대하증은 몸 전체나 신체 일부분의 혈액 순환이 원활하지 않아 생기는 일종의 순환 장애 같은 것으로 여성의 성기에는 분비되는 분비물인 냉의 양이 많아지는 증상이다. 이 분비물이 생기는 이유는 각종 유해세균으로부터 생식기를 보호하기 위한 자연스러운 현상이지만, 그 분비물의 양이 많아지면 속옷에 심하게 묻고 양이 많아 늘 습하고 눅눅한 상태로 이어져서 냄새가 나며, 질염의 가장 흔한 원인균인 칸디다 알비칸스(candida albicans)의 노출되기 쉽다.Hypogonadism is a type of circulation disorder caused by poor circulation of the entire body or parts of the body, and is a symptom of an increase in the amount of cold, a secretion secreted in the female genitals. The reason for this secretion is a natural phenomenon to protect the genital organs from various harmful bacteria, but when the amount of the secretion increases, it is heavily buried in the underwear, and the amount is always moist and moist, leading to a smell, and the most common cause of vaginitis. Candida albicans is susceptible to exposure.

본 발명은 상기와 같은 질환의 예방 및 치료를 위한 것으로, 질과 관련된 질환의 예방 및 치료에는 모두 사용 가능하며, 상기 예시에 국한되지 않는다.The present invention is for the prevention and treatment of diseases as described above, and can be used for both prevention and treatment of diseases related to the vagina, and is not limited to the above examples.

상기 조성물은 진균류인 칸디다알비칸스(Candida albicans)에 항균 활성 효과가 있는 것을 포함한다.The composition includes those having an antimicrobial effect on the fungus Candida albicans.

상기 진균류에는 칸디다 알비칸스(Candida albicans), 칸디다 트로피칼리스(Candidan tropicalis) 및 칸디다 글라브라타(Candida glabrata) 등이 있으며, 이중 칸디다 알비칸스(Candida albicans)가 질염의 가장 흔한 원인균으로 85-90%정도를 차지한다.The fungi include Candida albicans, Candidan tropicalis, and Candida glabrata, among which Candida albicans is 85-90% of the most common cause of vaginitis. Occupies the degree.

그러나, 칸디다 알비칸스 이외의 칸디다에 의한 외음 질염의 발생 빈도가 점진적으로 증가하는 추세로 칸디다 진균류는 질뿐 아니라 구강, 기관지, 장 등에도 존재하며 건강한 신체에서도 흔히 볼 수 있어 상기 진균류의 항균 활성 효과를 나타내는 조성물이 필요하다.However, as the incidence of vulvovaginitis caused by Candida other than Candida albicans is gradually increasing, Candida fungi are present not only in the vagina, but also in the oral cavity, bronchi, and intestines, and are commonly found in healthy bodies, thus exhibiting the antimicrobial activity of the fungi. You need a composition that represents.

바람직하게 상기 항균 활성은 진균류인 칸디다 알비칸스(Candida albicans), 칸디다 트로피칼리스(Candidan tropicalis) 및 칸디다 글라브라타(Candida glabrata)의 발육과 생활 기능을 저지 또는 억제할 수 있는 것으로 질염 원인균을 살균하는 것이다.Preferably, the antimicrobial activity is capable of inhibiting or inhibiting the development and life function of the fungi Candida albicans, Candida tropicalis, and Candida glabrata. will be.

상기 수용성 비타민은 비타민 C, 비타민 B1, 비타민 B2, 니아신, 비타민 B6, 비타민 B12, 엽산 및 비오틴으로 이루어진 군으로부터 선택되는 것을 포함한다.The water-soluble vitamins include those selected from the group consisting of vitamin C, vitamin B1, vitamin B2, niacin, vitamin B6, vitamin B12, folic acid, and biotin.

상기 수용성 비타민은 비타민 C, 비타민 B1, 비타민 B2, 니아신, 비타민 B6, 비타민 B12, 엽산 및 비오틴으로 이루어진 군으로부터 선택될 수 있지만, 바람직하게는 비타민 C, 즉 아스코르빈산을 포함하는 것을 특징으로 하지만, 예시에 국한되지 않는다.The water-soluble vitamin may be selected from the group consisting of vitamin C, vitamin B1, vitamin B2, niacin, vitamin B6, vitamin B12, folic acid, and biotin, but preferably includes vitamin C, that is, ascorbic acid. , Is not limited to examples.

상기 수용성 비타민, 바람직하게는 아스코르빈산을 포함하는 것은 질 내의 pH를 약산성으로 유지하여 항염 효과를 나타내기 위한 것이다. 일반적으로, 여성 청결제용 조성물은 질 내의 pH를 약산성으로 유지시키기 위해, 나트륨염, 젖산 완충 용액 등을 사용하였다. 이는 질 내의 pH를 약산성을 유지시키기 위해 첨가한 성분임에 반해, 본 발명에서의 아스코르빈산은 질 내의 약산성 환경의 유지에 더불어, 항산화 효과, 피부 조직의 성장과 회복, 암 유발물질 생성 방지 등의 효과를 나타낼 수 있다.The water-soluble vitamin, preferably ascorbic acid, is included in order to exhibit an anti-inflammatory effect by maintaining the pH in the vagina to be weakly acidic. In general, the composition for feminine cleansers used sodium salt, lactic acid buffer solution, etc. in order to maintain the pH in the vagina as weakly acidic. While this is an ingredient added to maintain a weakly acidic pH in the vagina, ascorbic acid in the present invention has antioxidant effects, growth and recovery of skin tissue, prevention of cancer-causing substances, etc., as well as maintaining a weakly acidic environment in the vagina. Can show the effect of.

상기 조성물은 기타 첨가제를 추가로 포함하며, 상기 기타 첨가제는 부형제, 붕해제 및 활택제인 것을 포함한다.The composition further includes other additives, and the other additives include excipients, disintegrants and lubricants.

상기 부형제는 프로솔브, 전분, 미결정 셀룰로오스, 만니톨, 유당, 저치환하이드록시프로필셀룰로오스, 슈크랄로스 및 이들의 혼합물로 이루어진 군으로부터 선택되며, 구체적으로 프로솔브(프로솔브 SMCC90), 전분(Starch 1500), 미결정 셀룰로오스(미결정 셀룰로오스 PH102) 및 만니톨(만니톨 160C)를 포함할 수 있으나, 상기 예시에 국한되지 않는다. The excipient is selected from the group consisting of Prosolve, starch, microcrystalline cellulose, mannitol, lactose, low-substituted hydroxypropyl cellulose, sucralose, and mixtures thereof, specifically Prosolve (Prosolve SMCC90), starch (Starch 1500 ), microcrystalline cellulose (microcrystalline cellulose PH102), and mannitol (mannitol 160C), but are not limited to the above examples.

상기 붕해제는 크로스포비돈, 전분글로콘산 나트륨, 크로스카멜로오스나트륨, 폴리소르베이트, 라이릴황산나트륨 및 이들의 혼합물로 이루어진 군으로부터 선택되며, 보다 구체적으로 크로스포비돈(크로스포비돈CL-SF)이며, 상기 예시에 국한되지 않는다.The disintegrant is selected from the group consisting of crospovidone, sodium starch gluconate, croscarmellose sodium, polysorbate, sodium lyryl sulfate, and mixtures thereof, and more specifically crospovidone (crospovidone CL-SF), It is not limited to the above example.

상기 활택제는 스테아르산 마그네슘, 경질무수규산, 탈크, 글리세릴베헤네이트 및 이들의 혼합물로 이루어진 군으로부터 선택되며, 보다 구체적으로 스타아르산마그네슘이며, 상기 예시에 국한되지 않는다.The lubricant is selected from the group consisting of magnesium stearate, light anhydrous silicic acid, talc, glyceryl behenate, and mixtures thereof, and more specifically magnesium stararate, and is not limited to the above examples.

바람직하게 본 발명의 일 실시예에 따른, 여성 청결제용 조성물은 프로폴리스 0.2 내지 3.0 중량%, 콜라겐 펩타이드 0.1 내지 1.5 중량%, 흑효모 0.1 내지 1.5 중량%, 키토산 0.1 내지 1.5 중량%, 당귀 추출물 0.1 내지 1.5 중량%, 병풀 추출물 0.1 내지 1.5 중량%, 자몽씨 추출물 0.1 내지 1.5 중량%, 수용성 비타민 0.5 내지 5 중량%, 프로솔브 15 내지 30 중량%, 전분 15 내지 30 중량%, 미결정 셀룰로오스 10 내지 20 중량%, 만니톨 20 내지 40 중량%, 크로스포비돈 1 내지 10 중량% 및 스테아린산마그네슘 0.5 내지 5 중량%를 포함할 수 있다.Preferably, according to an embodiment of the present invention, the composition for a feminine cleanser is 0.2 to 3.0% by weight of propolis, 0.1 to 1.5% by weight of collagen peptide, 0.1 to 1.5% by weight of black yeast, 0.1 to 1.5% by weight of chitosan, 0.1 to 1.5% by weight of angelica extract To 1.5% by weight, centella asiatica extract 0.1 to 1.5% by weight, grapefruit seed extract 0.1 to 1.5% by weight, water-soluble vitamins 0.5 to 5% by weight, Prosolve 15 to 30% by weight, starch 15 to 30% by weight, microcrystalline cellulose 10 to 20 It may include weight %, mannitol 20 to 40 weight %, crospovidone 1 to 10 weight %, and magnesium stearate 0.5 to 5 weight %.

상기 여성 청결제용 조성물은 프로폴리스 0.2 중량% 미만으로 포함할 경우, 항균, 항염 및 항산화 효과가 미비한 문제가 발생하며, 3.0 중량%를 초과하여 포함할 경우, 발진 및 호흡 곤란의 문제가 발생할 수 있다.When the composition for feminine cleansing agent contains less than 0.2% by weight of propolis, a problem of insufficient antibacterial, anti-inflammatory and antioxidant effects occurs, and when it contains more than 3.0% by weight, problems of rash and shortness of breath may occur. .

상기 콜라겐 펩타이드는 전체 중량에 대하여, 0.1 중량% 미만으로 포함할 경우, 탄력 증진 및 피부 재생 효과가 미비한 문제가 있으며, 1.5 중량%를 초과하여 포함할 경우, 여드름 발생 및 알레르기 반응이 유발되는 문제가 있다.When the collagen peptide is included in an amount of less than 0.1% by weight based on the total weight, there is a problem that the elasticity enhancement and skin regeneration effect is insufficient, and when it is included in more than 1.5% by weight, acne occurrence and allergic reactions are caused. have.

따라서, 상기 범위 내에서 여성 청결제용 조성물로 사용 시 질과 관련된 질환의 예방 또는 치료를 위한 보습, 피부 탄력, 항균 및 항진균 효과가 우수한 여성 청결제용 조성물을 제공할 수 있다.Therefore, when used as a composition for a feminine cleanser within the above range, it is possible to provide a composition for a feminine cleanser having excellent moisturizing, skin elasticity, antibacterial and antifungal effects for the prevention or treatment of diseases related to the vagina.

상기 조성물은 세정 조성물 또는 질내 삽입용 정제인 조성물인 것을 포함한다.The composition includes a composition that is a cleaning composition or a tablet for vaginal insertion.

본 발명은 여성 청결제용 조성물로, 상기 제형은 비경구 투여를 위한 제제일 수 있고, 일 실시예로 액제, 겔(gel)제, 세정 조성물, 질내 삽입용 정제, 좌제 형태, 크림, 연고, 드레싱 용액, 분무제, 기타 도포제등의 국소 투여제, 용액형, 현탁형, 유제형 등의 액상 제형일 수 있으며, 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조제제, 좌제, 크림, 연고, 젤리, 거품, 세척제 또는 질 삽입물, 바람직하게는 액제, 겔(gel)제, 세정 조 성물, 질내 삽입용 정제 등의 피부 외용제가 포함될 수 있다. The present invention is a composition for a feminine cleanser, the formulation may be a formulation for parenteral administration, and in one embodiment, a solution, a gel, a cleaning composition, a tablet for vaginal insertion, a suppository form, a cream, an ointment, a dressing It may be a liquid formulation such as a solution, a spray, and other coating agents, a solution type, a suspension type, an emulsion type, etc., and a sterilized aqueous solution, a non-aqueous solution, a suspension, an emulsion, a freeze-dried preparation, a suppository, a cream, an ointment, Jelly, foam, detergents or vaginal inserts, preferably liquids, gels, cleaning compositions, and tablets for vaginal insertion may be included.

상기 제형은 일 예로 멸균수에 용해보조제, 유화 제, pH 조절을 위한 완충제 등을 첨가하여 제조할 수 있다. 상기 비수성용제 또는 현탁용제로는 프로필렌글리콜(propylene glycol), 폴리에틸렌글리콜(polyethylene glycol), 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. The formulation may be prepared by adding, for example, a dissolution aid, an emulsifier, a buffer for pH adjustment, etc. to sterile water. As the non-aqueous solvent or suspension solvent, propylene glycol, polyethylene glycol, vegetable oil such as olive oil, and injectable ester such as ethyl oleate may be used.

상기 좌제로는 위텝솔(witepsol), 마크로골, 트윈 61(tween 61), 카카오지, 라우린지, 글리세로 젤라틴 등이 사용될 수 있다. 보다 구체적으로, 상기 여성 청결제용 조성물은 상기 항균 조성물에 추가하여 이를 제형화하기 위한 담체를 포함할 수 있다. 상기 담체는 결합제, 활탁제, 현탁용제, 가용화제, 완충제, 보존제, 윤활제, 등장제, 안정화제, 분산제, 현탁화제, 색소, 향료 등을 사용할 수 있다.As the suppository, witepsol, macrogol, tween 61, cacao butter, laurin paper, glycero gelatin, and the like may be used. More specifically, the composition for feminine cleaner may include a carrier for formulating it in addition to the antibacterial composition. As the carrier, a binder, a lubricant, a suspension solvent, a solubilizing agent, a buffering agent, a preservative, a lubricant, an isotonic agent, a stabilizer, a dispersing agent, a suspending agent, a coloring agent, a fragrance, and the like may be used.

본 발명의 일 실시예에 따른, 여성 청결제용 조성물의 바람직한 투여량은 환자의 상태 및 체중, 질병의 정도, 약물형태, 투여경로 및 기간에 따라 다르지만, 당업자에 의해 적절하게 선택될 수 있다. According to an embodiment of the present invention, the preferred dosage of the composition for feminine cleansing agent varies depending on the condition and weight of the patient, the degree of disease, the drug type, the route and duration of administration, but may be appropriately selected by those skilled in the art.

본 발명의 일 실시예에 따른, 여성 청결제용 조성물의 투여량은 투여방법, 복용자의 연령, 성별 및 체중, 및 질환의 중증도 등을 고려하여 당업자에 의해 적절하게 선택될 수 있다. 일 실시예로, 조성물을 기준으로 할 때, 0.0001mg/kg 내지 1000mg/kg으로, 보다 효과적이기 위해서는 0.01mg/kg 내지 100mg/kg으로 투여할 수 있다. 투여는 하루에 한번 투여할 수도 있고, 수 회 나누어 투여할 수도 있다. 상기 투여량은 어떠한 면으로든 본 발명의 범위를 한정하는 것은 아니다.According to an embodiment of the present invention, the dosage of the composition for feminine cleansing agent may be appropriately selected by those skilled in the art in consideration of the administration method, the age, sex and weight of the user, and the severity of the disease. In one embodiment, based on the composition, it may be administered in 0.0001mg/kg to 1000mg/kg, and in order to be more effective, 0.01mg/kg to 100mg/kg. Administration may be administered once a day, or may be divided several times. The above dosage does not in any way limit the scope of the present invention.

또한, 본 발명의 일 실시예에 따른 여성 청결제용 조성물은 항균조성물 이외에 공지의 질과 관련된 질환에 억제활성을 갖는 화합물 또는 천연 추출물을 더욱 포함할 수 있다.In addition, the composition for feminine cleansing agent according to an embodiment of the present invention may further include a compound or natural extract having inhibitory activity against known vaginal-related diseases in addition to the antibacterial composition.

발명의 일 실시예에 따른 여성 청결제용 조성물은 인간을 포함한 동물에 직접 적용될 수 있다. 상기 동물은 식물에 대응하는 생물군으로 주로 유기물을 영양분으로 섭취하며, 소화나 배설 및 호흡기관이 분화되어 있는 것을 말하고, 상세하게는 척추동물, 더욱 상세하게는 포유류일 수 있다. 상기 포유류는 상세하게는 인간일 수 있다.The composition for a feminine cleaner according to an embodiment of the present invention may be applied directly to animals including humans. The animal is a group of organisms corresponding to plants, mainly ingesting organic matter as nutrients, and refers to that the digestion, excretion and respiratory organs are differentiated, and in detail, it may be a vertebrate, more specifically, a mammal. Specifically, the mammal may be a human.

상기 조성물은 제2 천연 추출물을 추가로 포함하며, 상기 제2 천연 추출물은 구릿대 추출물, 섬바디 추출물, 대극 추출물 및 이들의 혼합물로 이루어진 군에서 선택되는 것을 포함한다,The composition further comprises a second natural extract, and the second natural extract includes one selected from the group consisting of beetroot extract, island body extract, counter electrode extract, and mixtures thereof.

바람직하게 본 발명의 여성 청결제용 조성물은 상기 천연 추출물 이외에 구릿대 추출물, 섬바디 추출물, 대극 추출물 및 이들의 혼합물로 이루어진 군에서 선택되는 것을 추가로 포함할 수 있다.Preferably, the composition for feminine cleansing agent of the present invention may further include those selected from the group consisting of guret extract, island body extract, counter electrode extract, and mixtures thereof in addition to the natural extract.

구릿대(Angelica dahurica BENTH)는 쌍떡잎식물 산형화목 미나리과의 두해살이 또는 세해살이풀로, 굵은 뿌리 줄기를 가지고 있으며, 줄기는 곧게 서고 가지를 치면서 1.5m 정도의 높이로 자란다. 잎은 깃털 모양으로 두 번 갈라지며 갈라진 조각은 타원 또는 피침 모양으로 끝이 뾰족하고 가장자리는 고르지 않게 갈라지거나 톱니로 되어 있다. 전국적으로 분포하고 있으며 산속의 시냇가 등 물기가 많은 곳에 난다. 진통, 소종의 효능이 잇으며, 적용질환은 두통, 편두통, 각종 신경통, 치통, 복통 등이다.Angelica dahurica BENTH (Angelica dahurica BENTH) is a biennial or triennial plant of the parsley family, a dicotyledonous plant, and has a thick rhizome, and the stem stands upright and grows to a height of 1.5m while pruning branches. The leaves are divided twice in the shape of a feather, and the broken pieces are oval or lanceolate, with a sharp tip, and the edges are unevenly split or serrated. It is distributed nationwide, and it grows in wet places such as mountain streams. It has the effect of pain relief and small bells, and the applied diseases include headache, migraine, various neuralgia, toothache, and abdominal pain.

섬바디(Dystaenia takesimana (NAK.) KITAGAWA.)는 쌍떡잎식물 산형화목 미나리과의 여러해살이풀로, 울릉도 전역에 걸쳐서 자라는 다년초이며 울릉도에서는 돼지가 잘 먹는다고 돼지풀이라고 한다. 키가 2m 정도까지 자라는 다년초이며 4∼5개의 마디가 있다. 줄기는 속이 비었고 잎은 어긋난다. 잎자루가 길고 밑부분이 넓어져서 원줄기를 감싼다. 한방에서는 뿌리를 약초로 쓰는데 청열, 해독, 산풍, 소담, 하기 등에 효능이 있다.Island body (Dystaenia takesimana (NAK.) KITAGAWA.) is a perennial plant of the Aperaceae family of dicotyledons. It is a perennial plant that grows all over Ulleungdo. It is said to be ragweed that pigs eat well in Ulleungdo. It is a perennial plant that grows up to 2m tall and has 4-5 nodes. The stem is hollow and the leaves are dislocated. The petiole is long and the bottom part is wide, so it wraps around the main stem. In oriental medicine, the root is used as a medicinal herb, and it is effective in cheongyeol, detoxification, sanpung, sodam, and hagi.

상기 대극(Euphorbia pekinensis Rupr.)은 산야에 자라는 다년초로 높이가 80cm에 달하고 뿌리가 굵으며 곧추 자란다. 잎은 호생하며 둔두 또는 예두이고 예저이며 뒷면은 흰빛이 돌고 가장자리에 잔톱니가 있다. 꽃은 녹황색으로 6월에 원줄기 끝에 달린다. 열매는 삭과로 사마귀 같은 돌기가 있으며 종자는 넓은 타원형이며 겉은 밋밋하다.The Euphorbia pekinensis Rupr. is a perennial plant growing in the mountains and reaches 80 cm in height, has thick roots, and grows upright. Leaves grow alternately, obtuse or acute, acute, the back side is white and there are fine serrations at the edge. The flower is greenish yellow and hangs at the end of the main stem in June. Fruits are capsules, with wart-like projections, and seeds are wide oval and flat outside.

상기 구릿대 추출물, 섬바디 추출물 및 대극 추출물을 추가로 포함함에 따라, 각 구성 성분 간의 혼합 작용으로 인해 질과 관련된 질환의 예방 또는 치료를 위한 보습, 피부 탄력, 항균 및 항진균 효과가 상승하게 된다.As the above extract, island body extract, and counter electrode extract are additionally included, moisturizing, skin elasticity, antibacterial and antifungal effects for the prevention or treatment of diseases related to the vagina are increased due to the mixing action between the respective constituents.

또한, 상기 천연 추출물을 복합으로 사용하는 경우, 질과 관련된 질환의 예방 또는 치료를 위한 우수한 보습, 피부 탄력, 항균 및 항진균 효과를 나타내는 동시에 천연 추출물에 의해 자극이 거의 없는 여성 청결제용 조성물로의 제공을 가능하게 한다.In addition, when the natural extract is used in combination, it provides excellent moisturizing, skin elasticity, antibacterial and antifungal effects for the prevention or treatment of diseases related to the vagina, and at the same time provides a composition for feminine cleansers with little irritation by natural extracts. Makes it possible.

바람직하게 본 발명의 일 실시예에 따른, 여성 청결제용 조성물은 프로폴리스 0.2 내지 3.0 중량%, 콜라겐 펩타이드 0.1 내지 1.5 중량%, 구릿대 추출물 0.1 내지 1.5 중량%, 섬바디 추출물 0.1 내지 1.5 중량%, 대극 추출물 0.1 내지 1.5 중량%, 흑효모 0.1 내지 1.5 중량%, 키토산 0.1 내지 1.5 중량%, 당귀 추출물 0.1 내지 1.5 중량%, 병풀 추출물 0.1 내지 1.5 중량%, 자몽씨 추출물 0.1 내지 1.5 중량%, 수용성 비타민 0.5 내지 5 중량%, 프로솔브 15 내지 30 중량%, 전분 15 내지 30 중량%, 미결정 셀룰로오스 10 내지 20 중량%, 만니톨 20 내지 40 중량%, 크로스포비돈 1 내지 10 중량% 및 스테아린산마그네슘 0.5 내지 5 중량%를 포함할 수 있다.Preferably, according to an embodiment of the present invention, the composition for feminine cleansing agent is 0.2 to 3.0% by weight of propolis, 0.1 to 1.5% by weight of collagen peptide, 0.1 to 1.5% by weight of beetroot extract, 0.1 to 1.5% by weight of island body extract, and counteract extract 0.1 to 1.5% by weight, black yeast 0.1 to 1.5% by weight, chitosan 0.1 to 1.5% by weight, Angelicae extract 0.1 to 1.5% by weight, centella extract 0.1 to 1.5% by weight, grapefruit seed extract 0.1 to 1.5% by weight, water-soluble vitamin 0.5 to 5% by weight, 15 to 30% by weight of Prosolve, 15 to 30% by weight of starch, 10 to 20% by weight of microcrystalline cellulose, 20 to 40% by weight of mannitol, 1 to 10% by weight of crospovidone, and 0.5 to 5% by weight of magnesium stearate. Can include.

본 발명의 천연 추출물을 포함하는 여성 청결제용 조성물에 의하면, 질과 관련된 질환의 예방 또는 치료 효과를 나타내는 동시에 천연 추출물을 포함하여, 사용 시 자극이 거의 없고, 보다 건강한 환경을 제공할 수 있다.According to the composition for a feminine cleansing agent comprising the natural extract of the present invention, it exhibits the effect of preventing or treating diseases related to the vagina, and at the same time, including the natural extract, there is little irritation when used, and a healthier environment can be provided.

도 1은 본 발명의 일 실시예에 따른 여성 청결제용 조성물을 정제수에 녹인 이후, pH를 측정한 결과에 대한 사진이다.
도 2는 본 발명의 일 실시예에 따른 여성 청결제용 조성물의 보습 효과에 관한 실험 결과이다.
1 is a photograph of a result of measuring pH after dissolving a composition for a female cleanser according to an embodiment of the present invention in purified water.
2 is an experimental result of the moisturizing effect of a composition for a female cleanser according to an embodiment of the present invention.

이하, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 본 발명의 실시예에 대하여 상세히 설명한다. 그러나 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 여기에서 설명하는 실시예에 한정되지 않는다.Hereinafter, embodiments of the present invention will be described in detail so that those skilled in the art can easily implement the present invention. However, the present invention may be implemented in various different forms and is not limited to the embodiments described herein.

[제조예: 여성 청결제용 조성물의 제조][Production Example: Preparation of composition for feminine cleaner]

1. 여성 청결제용 조성물의 제조One. Preparation of composition for feminine cleaner

프로폴리스, 콜라겐 펩타이드, 흑효모, 키토산, 당귀 추출물, 병풀 추출물 및 자몽씨 추출물을 믹서로 분쇄하고, 이를 30 메쉬(mesh) 체로 사과하여 제 1혼합물로 제조하였으며, 부형제인 프로솔브 SMCC90, 전분 Starch1500, 미결정셀룰로오스 PH102, 만니톨 160C, 수용성 비타민인 아스코르빈산, 붕해제인 크로스포비돈 CL-SF을 30 메쉬 체에 넣고 사과하여 제2 혼합물을 제조하였다.Propolis, collagen peptide, black yeast, chitosan, angelica extract, centella asiatica extract and grapefruit seed extract were pulverized with a mixer, and apologized through a 30 mesh sieve to prepare the first mixture, excipients Prosolve SMCC90, starch Starch1500 , Microcrystalline cellulose PH102, mannitol 160C, ascorbic acid as a water-soluble vitamin, and crospovidone CL-SF as a disintegrant were put in a 30 mesh sieve and apologized to prepare a second mixture.

상기 제조된 제1 혼합물과 제2 혼합물을 혼합하고, 활택제인 스테아린산마그네슘 0.89 중량%를 넣고 혼합 타정하여, 여성 청결제용 조성물을 제조하였다.The prepared first mixture and the second mixture were mixed, and 0.89% by weight of magnesium stearate as a lubricant was added thereto, followed by mixing and tableting to prepare a composition for a feminine cleaner.

보다 구체적인 함량은 하기 표 1과 같이 제조하였다.More specific content was prepared as shown in Table 1 below.

실험번호Experiment number 프로폴리스Propolis 콜라겐 펩타이드Collagen peptide 흑효모Black yeast 키토산Chitosan 당귀 추출물Angelica extract 병풀 추출물Centella asiatica extract 자몽씨 추출물Grapefruit seed extract IV 1IV 1 0.50.5 0.30.3 0.10.1 0.10.1 0.10.1 0.10.1 0.10.1 IV 2IV 2 0.50.5 0.30.3 0.30.3 0.30.3 0.30.3 0.30.3 0.30.3 IV 3IV 3 1One 0.30.3 1One 1One 1One 1One 1One IV 4IV 4 1One 0.30.3 1.51.5 1.51.5 1.51.5 1.51.5 1.51.5 IV 5IV 5 33 0.30.3 1.51.5 1.51.5 1.51.5 1.51.5 1.51.5 IV 6IV 6 0.40.4 0.30.3 -- 0.30.3 0.30.3 0.30.3 0.30.3 IV 7IV 7 0.40.4 0.30.3 0.30.3 -- 0.30.3 0.30.3 0.30.3 IV 8IV 8 0.40.4 0.30.3 0.30.3 0.30.3 -- 0.30.3 0.30.3 IV 9IV 9 0.40.4 0.30.3 0.30.3 0.30.3 0.30.3 -- 0.30.3 IV 10IV 10 0.40.4 0.30.3 0.30.3 0.30.3 0.30.3 0.30.3 --

(단위: 중량%, 부형제인 프로솔브 SMCC90 25.56 중량%, 미결정셀룰로오스 PH102 14.84 중량%, 만니톨 160C 29.67 중량%, 수용성 비타민인 아스코르빈산 1.13 중량%, 붕해제인 크로스포비돈 CL-SF 4.45 중량%, 나머지 전분 Starch1500)(Unit: wt%, excipient Prosolve SMCC90 25.56 wt%, microcrystalline cellulose PH102 14.84 wt%, mannitol 160C 29.67 wt%, water-soluble vitamin ascorbic acid 1.13 wt%, disintegrant crospovidone CL-SF 4.45 wt%, The remaining starch Starch1500)

2. 제 2 천연 추출물을 포함하는 여성 청결제용 조성물2. Composition for feminine cleansing agent containing the second natural extract

상기 여성 청결제용 조성물(IV 2)의 제조 방법과 동일한 성분 함량 및 제조 방법을 이용하여, 제 2 천연 추출물인 구릿대 추출물, 섬바디 추출물 및 대극 추출물을 추가로 넣어 하기 표 2과 같은 구체적인 함량으로 여성 청결제용 조성물을 제조하였다.Using the same ingredient content and manufacturing method as the method for preparing the composition for female cleanser (IV 2), a female cleanser in a specific content as shown in Table 2 below by additionally adding the second natural extract, Guritdae extract, island body extract, and Daegeuk extract. A composition for use was prepared.

실험번호Experiment number 구릿대 추출물Honeysuckle extract 섬바디 추출물Island Body Extract 대극 추출물Counter electrode extract IT 1IT 1 0.050.05 0.050.05 0.050.05 IT 2IT 2 0.30.3 0.30.3 0.30.3 IT 3IT 3 0.50.5 0.50.5 0.50.5 IT 4IT 4 1One 1One 1One IT 5IT 5 1.51.5 1.51.5 1.51.5 IT 6IT 6 22 22 22

(단위: 중량%)(Unit: wt%)

[실험예 1: 칸다다알비칸스에 대한 항균력 평가][Experimental Example 1: Evaluation of antibacterial activity against Candada albicans]

전 배양된 칸디다 알비칸스 (Candida albicans)를 디스크 확산법 측정용 평판배지(Sabouraud [0057] Dextrose Agar.Difco.USA)에 100 ㎕씩 분주하여 도말한 후, 상기 제조된 실험번호 IV 1 내지 10 및 IT 1 내지 6의 여성 청결제용 조성물을 멸균된 페이퍼 디스크에 5mg/disc의 농도로 시료를 점적한 후 배지 위에 올려놓았다. After spreading the pre-cultured Candida albicans (Candida albicans) in a plate medium for measuring the disk diffusion method (Sabouraud Dextrose Agar.Difco.USA) by 100 µl and smeared, the prepared experiment numbers IV 1 to 10 and IT After dropping a sample at a concentration of 5 mg/disc on a sterilized paper disc of compositions for feminine cleaners 1 to 6, it was placed on the medium.

이에 대한 대조군으로 항진균제인 이트라코나졸 (Itraconazol)을 페이퍼디스크에 100㎍/disk의 농도로 시료를 점적한 후 배지 위에 올려놓았다. 이 평판배지를 28℃에서 48시간 동안 배양한 후 생육저지환(Clean Zone)의 크기를 측정하였다. 그 결과를 하기 표 3에 나타내었다. As a control for this, an antifungal agent, Itraconazol, was dropped onto a paper disk at a concentration of 100 µg/disk and then placed on a medium. After culturing the plate medium at 28° C. for 48 hours, the size of the growth inhibition ring (Clean Zone) was measured. The results are shown in Table 3 below.

하기 표 3에서 보는 바와 같이 본 발명의 여성 청결제용 조성물이 대조군인 이트라코나졸(항진균제, 특허 10-0592066)에 비해 강한 생육저지효과를 나타내었다.As shown in Table 3 below, the composition for a female cleanser of the present invention exhibited a strong growth inhibition effect compared to itraconazole (antifungal agent, patent 10-0592066) as a control group.

생육저지환 크기 (mm)Growth inhibition ring size (mm) IV 1IV 1 3030 IV 2IV 2 2727 IV 3IV 3 2626 IV 4IV 4 3131 IV 5IV 5 2727 IV 6IV 6 3434 IV 7IV 7 3232 IV 8IV 8 3434 IV 9IV 9 3232 IV 10IV 10 3131 IT 1IT 1 2929 IT 2IT 2 2828 IT 3IT 3 2525 IT 4IT 4 2424 IT 5IT 5 2727 IT 6IT 6 2929 대조군Control 3535

상기 표 3에 나타낸 바와 같이, 구릿대 추출물, 섬바디 추출물 및 대극 추출물을 추가로 포함하는 IT 1 내지 IT 6에서 생육저지환(Clean Zone)의 크기 감소 효과가 우수하였으며, IT 3 내지 IT 6에서 가장 우수한 생육저지환(Clean Zone)의 크기 감소 효과가 나타남을 확인하였다.As shown in Table 3, the effect of reducing the size of the growth inhibition ring (Clean Zone) was excellent in IT 1 to IT 6, which additionally includes a beetroot extract, an island body extract, and a counter electrode extract, and the best in IT 3 to IT 6 It was confirmed that the effect of reducing the size of the growth inhibition ring (Clean Zone) appeared.

따라서, 본 발명의 여성 청결제용 조성물은 칸디다 알비칸스 (Candida albicans)에 대한 강한 항균력이 있음을 확인하였다.Accordingly, it was confirmed that the composition for a feminine cleanser of the present invention has a strong antibacterial activity against Candida albicans.

[실험예 2: 가려움증 감소 효과 시험][Experimental Example 2: Itching reduction effect test]

가려움증을 느끼는 20세~40세의 여성 80명을 선정하여, 5명씩 16개 그룹으로 나누어, 실험번호 IV 1 내지 10 및 IT 1 내지 6의 여성 청결제용 조성물을 물에 희석시켜 10일 동안 사용하게 한 이후, 가려움 방지 효과를 평가하고, 그 결과를 표 4에 나타내었다. 점수는 10점부터 1점까지이며, 점수가 높을수록 가려움 방지 효과가 우수함을 나타낸다. 80 women aged 20 to 40 who feel itchy were selected and divided into 16 groups of 5 people, and the composition for feminine cleaners of experiment numbers IV 1 to 10 and IT 1 to 6 was diluted in water and used for 10 days. After that, the anti-itch effect was evaluated, and the results are shown in Table 4. The score ranges from 10 points to 1 point, and the higher the score, the better the anti-itch effect.

가려움 방지 효과Anti-itch effect IV 1IV 1 6.26.2 IV 2IV 2 7.47.4 IV 3IV 3 7.67.6 IV 4IV 4 5.65.6 IV 5IV 5 7.47.4 IV 6IV 6 3.23.2 IV 7IV 7 4.04.0 IV 8IV 8 3.43.4 IV 9IV 9 3.83.8 IV 10IV 10 4.24.2 IT 1IT 1 6.86.8 IT 2IT 2 7.27.2 IT 3IT 3 8.68.6 IT 4IT 4 8.88.8 IT 5IT 5 7.47.4 IT 6IT 6 7.07.0

상기 표 4에 나타낸 바와 같이, 구릿대 추출물, 섬바디 추출물 및 대극 추출물을 추가로 포함하는 IT 1 내지 IT 6에서 가려움증 감소 효과가 우수하였으며, IT 3 내지 IT 6에서 가장 우수한 가려움증 감소 효과가 나타남을 확인하였다.As shown in Table 4 above, it was confirmed that the itching reduction effect was excellent in IT 1 to IT 6, which additionally included the beetroot extract, the island body extract, and the counter electrode extract, and the most excellent itching reducing effect was shown in IT 3 to IT 6. .

[실험예 3: 피부 자극 발생 시험][Experimental Example 3: Skin irritation occurrence test]

실험예 2와 동일한 16개 그룹에 대해, 가려움 방지 효과 이외에 자극 발생 여부에 대한 설문 조사를 추가로 진행하였으며, 그 결과는 하기 표 5 및 표 6과 같다.For the same 16 groups as in Experimental Example 2, in addition to the anti-itch effect, a questionnaire on whether or not stimulation occurred was additionally conducted, and the results are shown in Tables 5 and 6 below.

[평가 기준][Evaluation standard]

◎: 전혀 자극이 없음◎: No stimulation at all

○: 거의 자극이 없음○: almost no stimulation

△: 약간의 자극이 있어, 민감한 점막에는 사용하지 않는 것이 바람직함△: There is a slight irritation, so it is preferable not to use it for sensitive mucous membranes.

Х: 자극이 심해, 사용이 불가함Х: Severe irritation, cannot be used

IV 1IV 1 IV 2IV 2 IV 3IV 3 IV 4IV 4 IV 5IV 5 IV 6IV 6 IV 7IV 7 IV 8IV 8 IV 9IV 9 IV 10IV 10 1One ХХ ХХ 22 ХХ ХХ ХХ ХХ 33 ХХ ХХ ХХ ХХ 44 ХХ ХХ 55 ХХ ХХ ХХ

IT 1IT 1 IT 2IT 2 IT 3IT 3 IT 4IT 4 IT 5IT 5 IT 6IT 6 1One 22 33 44 55

상기 표 5 및 6에 의하면, IV 1 내지 5의 경우에는 피부 자극이 거의 없는 것으로 평가된 반면, IV 6 및 IV 10은 피부 자극이 발생하였다.According to Tables 5 and 6, in the case of IV 1 to 5, it was evaluated that there was little skin irritation, whereas in the case of IV 6 and IV 10, skin irritation occurred.

IT 1 내지 IT 6의 경우에, 전반적으로 피부 자극이 심하지 않은 것으로 평가되었으며, IT 3 및 IT 4에서 가장 우수한 평가를 받았다.In the case of IT 1 to IT 6, overall skin irritation was evaluated as not severe, and IT 3 and IT 4 received the best evaluation.

[실험예 4: 보습성 평가][Experimental Example 4: Moisturizing property evaluation]

실험예 2와 동일한 16개 그룹에 대해, 자극 발생 여부 이외에 보습성에 대한 설문 조사를 추가로 진행하였으며, 그 결과는 하기의 도 2에 나타내었다.For the same 16 groups as in Experimental Example 2, a questionnaire survey was additionally conducted on moisturizing properties in addition to whether or not stimulation occurred, and the results are shown in FIG. 2 below.

하기 도 2에 나타낸 바와 같이, 구릿대 추출물, 섬바디 추출물 및 대극 추출물을 추가로 포함하는 IT 1 내지 IT 6에서 보습성능이 우수하였으며, IT 3 내지 IT 6에서 가장 우수한 보습 효과가 나타남을 확인하였다.As shown in FIG. 2 below, it was confirmed that the moisturizing performance was excellent in IT 1 to IT 6, which additionally includes a copper stalk extract, an island body extract, and a counter electrode extract, and the best moisturizing effect was shown in IT 3 to IT 6.

[실험예 5: 세정력 평가] [Experimental Example 5: Evaluation of cleaning power]

실험예 2와 동일한 16개 그룹에 대해, 가려움 방지 효과 이외에 여성 청결제로 사용시에 세정력, 청결감, 향에 대한 설문 조사를 추가로 진행하였으며, 그 결과는 하기 표 7 및 8과 같다.For the same 16 groups as in Experimental Example 2, in addition to the anti-itch effect, a questionnaire survey on detergency, cleanliness, and aroma when used as a female cleanser was further conducted, and the results are shown in Tables 7 and 8 below.

점수는 10점부터 1점까지이며, 점수가 높을수록 세정력, 청결감, 향 및 종합 기호도가 우수함을 나타낸다. The score ranges from 10 points to 1 point, and the higher the score, the better detergency, cleanliness, fragrance, and overall preference.

IV 1IV 1 IV 2IV 2 IV 3IV 3 IV 4IV 4 IV 5IV 5 IV 6IV 6 IV 7IV 7 IV 8IV 8 IV 9IV 9 IV 10IV 10 세정력Cleaning power 6.86.8 8.48.4 8.08.0 6.86.8 8.08.0 5.25.2 3.63.6 6.06.0 5.45.4 6.06.0 청결감Cleanliness 6.46.4 8.28.2 7.87.8 6.26.2 8.28.2 5.85.8 3.23.2 5.85.8 5.65.6 5.45.4 incense 6.26.2 8.48.4 8.28.2 7.47.4 8.08.0 3.03.0 6.06.0 5.25.2 6.06.0 5.65.6 종합 기호도Overall preference map 6.26.2 8.48.4 8.08.0 77 8.18.1 55 3.23.2 5.25.2 5.85.8 5.85.8

IT 1IT 1 IT 2IT 2 IT 3IT 3 IT 4IT 4 IT 5IT 5 IT 6IT 6 세정력Cleaning power 7.87.8 8.08.0 9.09.0 8.88.8 8.08.0 7.27.2 청결감Cleanliness 7.47.4 8.28.2 8.88.8 9.29.2 7.67.6 6.86.8 incense 7.27.2 8.48.4 8.28.2 8.48.4 7.47.4 7.27.2 종합 기호도Overall preference map 7.27.2 8.28.2 8.88.8 9.09.0 8.08.0 7.07.0

상기 표 7 및 표 8에 따르면, IV1 내지 IV3 및 IV 5가 세정력, 청결감, 향 및 종합 기호도에서 우수한 평가를 받았으며, 그 중에서도 IV2, IV3 및 IV5에서 가장 우수한 평가를 받았다.According to Tables 7 and 8, IV1 to IV3 and IV 5 received excellent evaluations in detergency, cleanliness, fragrance, and overall preference, and among them, IV2, IV3 and IV5 received the best evaluation.

또한, 구릿대 추출물, 섬바디 추출물 및 대극 추출물을 넣은 여성 청결제용 조성물의 경우에도 전반적으로 우수한 평가를 받았으며, 특히, IT 3 및 IT 4에서 가장 우수한 평가를 받았다.In addition, the composition for feminine cleansing agent containing the extract of Goridae, Island body extract, and Daepoleon received excellent overall evaluation, and in particular, received the best evaluation in IT 3 and IT 4.

이상에서 본 발명의 바람직한 실시예에 대하여 상세하게 설명하였지만 본 발명의 권리범위는 이에 한정되는 것은 아니고 다음의 청구범위에서 정의하고 있는 본 발명의 기본 개념을 이용한 당업자의 여러 변형 및 개량 형태 또한 본 발명의 권리범위에 속하는 것이다.Although the preferred embodiments of the present invention have been described in detail above, the scope of the present invention is not limited thereto, and various modifications and improvements by those skilled in the art using the basic concept of the present invention defined in the following claims are also present. It belongs to the scope of rights of

Claims (7)

프로폴리스; 콜라겐 펩타이드; 흑효모; 키토산;
당귀 추출물, 병풀 추출물, 자몽씨 추출물 및 이들의 혼합물로 이루어진 군으로부터 선택되는 천연 추출물; 및
수용성 비타민;
을 포함하는
여성 청결제용 조성물.
Propolis; Collagen peptide; Black yeast; Chitosan;
Angelicae extract, centella extract, grapefruit seed extract, and a natural extract selected from the group consisting of a mixture thereof; And
Water-soluble vitamins;
Containing
Composition for feminine cleansers.
제 1항에 있어서,
상기 조성물은 질과 관련된 질환의 예방 또는 치료를 위한 것으로, 상기 질과 관련된 질환은 질이완증, 질 건조증, 질 진균증 및 냉대하증인
여성 청결제용 조성물.
The method of claim 1,
The composition is for the prevention or treatment of diseases related to the vagina, the diseases related to the vagina are vaginal laxia, vaginal dryness, vaginal mycosis and hypochondriasis
Composition for feminine cleansers.
제 1항에 있어서,
상기 조성물은 진균류인 칸디다알비칸스(Candida albicans)에 향균 활성 효과가 있는 것인
여성 청결제용 조성물.
The method of claim 1,
The composition has an antibacterial effect on the fungus Candida albicans
Composition for feminine cleansers.
제1항에 있어서,
상기 수용성 비타민은 비타민 C, 비타민 B1, 비타민 B2, 니아신, 비타민 B6, 비타민 B12, 엽산 및 비오틴으로 이루어진 군으로부터 선택되는
여성 청결제용 조성물.
The method of claim 1,
The water-soluble vitamin is selected from the group consisting of vitamin C, vitamin B 1 , vitamin B 2 , niacin, vitamin B 6 , vitamin B 12 , folic acid and biotin.
Composition for feminine cleansers.
제 1항에 있어서,
상기 조성물은 기타 첨가제를 추가로 포함하며,
상기 기타 첨가제는 부형제, 붕해제 및 활택제인
여성 청결제용 조성물.
The method of claim 1,
The composition further comprises other additives,
The other additives are excipients, disintegrants and lubricants
Composition for feminine cleansers.
제 1항에 있어서,
상기 조성물은 세정 조성물 또는 질내 삽입용 정제인 조성물.
The method of claim 1,
The composition is a cleaning composition or a composition for vaginal insertion.
제1항에 있어서,
상기 조성물은 제2 천연 추출물을 추가로 포함하며,
상기 제2 천연 추출물은 구릿대 추출물, 섬바디 추출물 및 이들의 혼합물로 이루어진 군에서 선택되는
여성 청결제용 조성물.
The method of claim 1,
The composition further comprises a second natural extract,
The second natural extract is selected from the group consisting of beetroot extract, island body extract, and mixtures thereof
Composition for feminine cleansers.
KR1020190086098A 2019-07-17 2019-07-17 Cleansing composition for women's vagina comprising natural KR102224920B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020190086098A KR102224920B1 (en) 2019-07-17 2019-07-17 Cleansing composition for women's vagina comprising natural
CN202010206229.6A CN112237625A (en) 2019-07-17 2020-03-23 Composition for feminine cleanser comprising natural extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190086098A KR102224920B1 (en) 2019-07-17 2019-07-17 Cleansing composition for women's vagina comprising natural

Publications (2)

Publication Number Publication Date
KR20210010682A true KR20210010682A (en) 2021-01-28
KR102224920B1 KR102224920B1 (en) 2021-03-10

Family

ID=74170387

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190086098A KR102224920B1 (en) 2019-07-17 2019-07-17 Cleansing composition for women's vagina comprising natural

Country Status (2)

Country Link
KR (1) KR102224920B1 (en)
CN (1) CN112237625A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170077567A (en) * 2015-12-28 2017-07-06 주식회사 서울식연 Antimicrobial composition containing citrus extract or grapefruit seed extract, and hygiene preparation for pet animals
KR20170085703A (en) * 2016-01-15 2017-07-25 울산과학대학교 산학협력단 Composition for anti-inflammatory and inhibiting comprising extracts derived from natural materials
KR20180009293A (en) * 2016-07-18 2018-01-26 이예진 Natural oriental medicine mouthwash make of main ingredients is zizania latifolia and the manufacturing method the same
KR101951733B1 (en) * 2017-10-11 2019-02-25 (주)인벤티지랩 Cleansing composition for women's vagina comprising propolis and natural extracts and method for manufacturing the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100592915C (en) * 2007-03-13 2010-03-03 谷振江 Ecological vagina cleaning bacteriostasis liquid
KR101127928B1 (en) * 2009-07-23 2012-03-23 대전대학교 산학협력단 Anti atopic dermatitis containing extracts from extract of Dystaenia takeshimana as active ingredients
CN101829041B (en) * 2010-04-30 2012-02-01 北京欧凯纳斯科技有限公司 Sterilizing and itch-relieving gynaecological lotion
KR101345709B1 (en) * 2010-12-07 2013-12-30 콜마비앤에이치 주식회사 Antibacterial and antifungal composition and Ladies genital area cleanser composition comprising antibacterial and antifungal composition for preventing and treating vaginitis
KR101317477B1 (en) * 2012-12-28 2013-10-10 제주대학교 산학협력단 Antibacterial compositions of Carpinus laxiflora against fish disease bacteria
CN104606315A (en) * 2015-03-09 2015-05-13 李汶峰 External medicine for treating female vaginal itching and preparation method for external medicine
CN106539750A (en) * 2016-10-25 2017-03-29 天津市人意恒农业科技有限公司 A kind of feminine care gel and preparation method thereof
CN108096396A (en) * 2018-03-07 2018-06-01 西安璀璨生物科技有限责任公司 A kind of Traditional Chinese medicine gel composition antibacterial for vaginal mucosa

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170077567A (en) * 2015-12-28 2017-07-06 주식회사 서울식연 Antimicrobial composition containing citrus extract or grapefruit seed extract, and hygiene preparation for pet animals
KR20170085703A (en) * 2016-01-15 2017-07-25 울산과학대학교 산학협력단 Composition for anti-inflammatory and inhibiting comprising extracts derived from natural materials
KR20180009293A (en) * 2016-07-18 2018-01-26 이예진 Natural oriental medicine mouthwash make of main ingredients is zizania latifolia and the manufacturing method the same
KR101951733B1 (en) * 2017-10-11 2019-02-25 (주)인벤티지랩 Cleansing composition for women's vagina comprising propolis and natural extracts and method for manufacturing the same

Also Published As

Publication number Publication date
CN112237625A (en) 2021-01-19
KR102224920B1 (en) 2021-03-10

Similar Documents

Publication Publication Date Title
KR101345709B1 (en) Antibacterial and antifungal composition and Ladies genital area cleanser composition comprising antibacterial and antifungal composition for preventing and treating vaginitis
CN110464811A (en) A kind of gynaecology's foam antibacterial liquid and preparation method thereof
WO2008140200A1 (en) External compositions for the skin
KR101951733B1 (en) Cleansing composition for women's vagina comprising propolis and natural extracts and method for manufacturing the same
US20190008907A1 (en) Compositions for management of wounds, skin diseases, dehydration, chronic diseases, and respiratory diseases
CN110478477A (en) A kind of traditional Chinese biological preparation and preparation method thereof promoting female reproductive health
US20130108599A1 (en) Herbal Vaginal Compositions
CN104224923A (en) Tea tree essential oil antimicrobial gel for treating vaginal disease in gynecology
KR20160015718A (en) Feminine cleanser composition comprising Portulaca oleracea extract and Phytoncide
CN107456509B (en) A kind of external application biological agent and preparation method for vagina prevention, health care and treatment gynaecology genital inflammation
US10478463B2 (en) External-use medicament for cleaning and care of the ovaries, vagina, and vulva
KR20200062598A (en) A Feminine cleanser composition comprising imperata cylindrica leaf and artemisia princeps
EP3134099B1 (en) Anti-candida compositions and uses thereof
KR102224920B1 (en) Cleansing composition for women's vagina comprising natural
KR102237517B1 (en) Antifungal Composition Comprising Rose Extract and Scutellariae Radix Extract Having Synergistic Effect, and Composition for Preventing or Treating Candidasis
CN108619486B (en) Ointment for treating skin diseases and preparation method thereof
KR102575660B1 (en) External composition having antibacterial properties and feminine cleanser comprising the same
KR102413425B1 (en) Feminine cleanser composition comprising beta glucan and vacuum filling ampoule comprising the same
KR102245617B1 (en) Feminine cleanser comprising extract of rose and extract of Sanguisorba officinalis root
KR102248786B1 (en) Feminine cleanser comprising extract of mugwort and extract of Sanguisorba officinalis root
CN113491765A (en) Composition containing propolis and natural extract for female cleanser and preparation method thereof
KR101470282B1 (en) Pharmaceutical Composition comprising a combination of a salt and sugar for proventing or treating lax vagina syndrome or colpoxerosis disease and the use thereof
KR20120090123A (en) Composition of film forming solution for alleviation of menstrual cramp
KR20210054206A (en) Feminine cleanser comprising extract of mugwort and extract of rose
KR20230033519A (en) Feminine cleansing composition containing human stem cell culture

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant